Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 101 M104 M96 M99 M83 M109 M 387 M Research & development —————— — Operating income 149 M44 M85 M89 M139 M65 M 378 M Non-Operating Income, Total —————— — Interest expense, net of interest capitalized 23 M21 M22 M21 M22 M21 M 86 M Non-Operating Income, excl. Interest Expenses —————— — Unusual income/expense —————— — Pretax income 158 M42 M96 M102 M153 M77 M 428 M Equity in earnings —————— — Taxes 38 M11 M23 M23 M35 M18 M 99 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 120 M31 M73 M79 M118 M59 M 329 M Discontinued operations —————— — Net income 120 M31 M73 M79 M118 M59 M 329 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 120 M31 M73 M79 M118 M59 M 329 M Basic earnings per share (Basic EPS) 0.580.150.350.380.550.28 1.56 Diluted earnings per share (Diluted EPS) 0.570.150.350.380.550.28 1.56 Average basic shares outstanding 210.1 M210.3 M210.3 M210.3 M210.3 M210.6 M — Diluted shares outstanding 210.4 M210.3 M210.3 M210.4 M210.4 M211.8 M — EBITDA 180 M85 M130 M135 M182 M98 M 545 M EBIT 149 M53 M97 M100 M147 M65 M 409 M Cost of revenue 740 M629 M712 M698 M768 M670 M 2.85 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 33 M32 M33 M35 M35 M33 M 136 M